Pierrel operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other
pharmaceutical manufacturers in Europe:
Calliditas Therapeutics AB
sales of 184.83 million Swedish Kronor [US$20.89 million]
of which 100%
Celon Pharma SA
(102.25 million Polish New Zlotys [US$26.77 million]
Vistin Pharma ASA
based in NORWAY
(227.19 million Norwegian Kroner [US$24.48 million]
During the year ended December of 2019, sales at
Pierrel were 21.34 million Euro (US$25.11 million).
increase of 7.1%
versus 2018, when the company's sales were 19.93 million Euro.
This was the third consecutive year of growth at Pierrel.